These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 34944832)

  • 1. The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma.
    Schönefeldt S; Wais T; Herling M; Mustjoki S; Bekiaris V; Moriggl R; Neubauer HA
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and metabolic dichotomy of murine γδ T cell subsets in cancer immunity.
    Lopes N; Silva-Santos B
    Eur J Immunol; 2021 Jan; 51(1):17-26. PubMed ID: 33188652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
    Li Y; Li G; Zhang J; Wu X; Chen X
    Front Immunol; 2020; 11():619954. PubMed ID: 33664732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
    Liu Y; Zhang C
    Cells; 2020 May; 9(5):. PubMed ID: 32413966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer immunotherapy with γδ T cells: many paths ahead of us.
    Kabelitz D; Serrano R; Kouakanou L; Peters C; Kalyan S
    Cell Mol Immunol; 2020 Sep; 17(9):925-939. PubMed ID: 32699351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of gammadelta T lymphocytes in tumor defense.
    Zocchi MR; Poggi A
    Front Biosci; 2004 Sep; 9():2588-604. PubMed ID: 15358583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms of Differentiation of Murine Pro-Inflammatory γδ T Cell Subsets.
    Serre K; Silva-Santos B
    Front Immunol; 2013 Dec; 4():431. PubMed ID: 24367369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic avenues for γδ T cells in cancer.
    Costa GP; Mensurado S; Silva-Santos B
    J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38007241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging roles of γδ T cells in cancer immunotherapy.
    Mensurado S; Blanco-Domínguez R; Silva-Santos B
    Nat Rev Clin Oncol; 2023 Mar; 20(3):178-191. PubMed ID: 36624304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. γδ T cells in cancer: a small population of lymphocytes with big implications.
    Raverdeau M; Cunningham SP; Harmon C; Lynch L
    Clin Transl Immunology; 2019; 8(10):e01080. PubMed ID: 31624593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. γδ T cells in cancer immunotherapy.
    Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
    Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective γδ T-cell clinical therapies: current limitations and future perspectives for cancer immunotherapy.
    Revesz IA; Joyce P; Ebert LM; Prestidge CA
    Clin Transl Immunology; 2024; 13(2):e1492. PubMed ID: 38375329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Responsiveness of Innate-like IL-17- and IFN-γ-Producing γδ T Cells to Homeostatic Cytokines.
    Corpuz TM; Stolp J; Kim HO; Pinget GV; Gray DH; Cho JH; Sprent J; Webster KE
    J Immunol; 2016 Jan; 196(2):645-54. PubMed ID: 26673141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting the Unconventionals: Importance of Immune Checkpoint Receptors in γδ T, MAIT, and NKT Cells.
    Catafal-Tardos E; Baglioni MV; Bekiaris V
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer.
    Silva-Santos B; Mensurado S; Coffelt SB
    Nat Rev Cancer; 2019 Jul; 19(7):392-404. PubMed ID: 31209264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
    Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
    Front Immunol; 2018; 9():1990. PubMed ID: 30298063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy.
    Lee D; Rosenthal CJ; Penn NE; Dunn ZS; Zhou Y; Yang L
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma/delta T cells as cellular vehicles for anti-tumor immunity.
    Wang CQ; Lim PY; Tan AH
    Front Immunol; 2023; 14():1282758. PubMed ID: 38274800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies.
    Zhou J; Kang N; Cui L; Ba D; He W
    Cell Mol Immunol; 2012 Jan; 9(1):34-44. PubMed ID: 21666706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γδ T cells and their potential for immunotherapy.
    Wu YL; Ding YP; Tanaka Y; Shen LW; Wei CH; Minato N; Zhang W
    Int J Biol Sci; 2014; 10(2):119-35. PubMed ID: 24520210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.